The Journal of craniofacial surgery · 2026
Pediatric Parotid Gland Masses: A 10-Year Experience of Clinical Spectrum, Management, and Long-Term Outcomes.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zu Jinyan, Lou Fan, Gao Yingqin, Ming Cheng, Ma Jing
Аннотация
PURPOSE: This study aims to summarize the spectrum, characteristics, treatment strategies, and long-term prognosis of pediatric parotid gland masses.
PATIENTS AND METHODS: The authors retrospectively reviewed 136 children who underwent surgeries for parotid gland masses from January 2015 to December 2024. This review analyzed data regarding clinical presentations, imaging examinations, postoperative pathologic findings, and the results of long-term follow-up (≥12 mo).
RESULTS: Congenital lesions were the most common, accounting for 63.2% (86/136) of cases, and included hemangiomas, lymphangiomas, and first branchial cleft fistulas. Pleomorphic adenomas of the parotid gland represented 15.4% (21/136), while all malignant tumors identified were lymphomas, comprising 6.6% (9/136). During a median follow-up period of 38 months, the incidence of temporary facial nerve palsy following surgery was recorded at 5.1% (7/136), and the overall recurrence rate was 7.4% (10/136). A total of 119 patients achieved complete remission, with no deaths occurring during the study period.
CONCLUSION: Benign lesions are the predominant type of parotid gland masses in children, and CT scans are vital for the diagnosis and preoperative assessment of these lesions. Surgery is the main treatment method. Long-term follow-up has shown that for vascular lymphatic malformations prone to recurrence, local injection of bleomycin is a safe and effective adjunctive therapy. This study provides empirical evidence for optimizing the clinical management pathway for this disease.
PATIENTS AND METHODS: The authors retrospectively reviewed 136 children who underwent surgeries for parotid gland masses from January 2015 to December 2024. This review analyzed data regarding clinical presentations, imaging examinations, postoperative pathologic findings, and the results of long-term follow-up (≥12 mo).
RESULTS: Congenital lesions were the most common, accounting for 63.2% (86/136) of cases, and included hemangiomas, lymphangiomas, and first branchial cleft fistulas. Pleomorphic adenomas of the parotid gland represented 15.4% (21/136), while all malignant tumors identified were lymphomas, comprising 6.6% (9/136). During a median follow-up period of 38 months, the incidence of temporary facial nerve palsy following surgery was recorded at 5.1% (7/136), and the overall recurrence rate was 7.4% (10/136). A total of 119 patients achieved complete remission, with no deaths occurring during the study period.
CONCLUSION: Benign lesions are the predominant type of parotid gland masses in children, and CT scans are vital for the diagnosis and preoperative assessment of these lesions. Surgery is the main treatment method. Long-term follow-up has shown that for vascular lymphatic malformations prone to recurrence, local injection of bleomycin is a safe and effective adjunctive therapy. This study provides empirical evidence for optimizing the clinical management pathway for this disease.